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Abstract 
The current review is aimed to deliver some updates on the ethnobotany, phytochemistry and biological 
activities of Beilschmiedia species in order to throw more light on their therapeutic potentials and future 
research priorities. Phytochemical studies on Beilschmiedia genus yielded essential oils, endiandric acid 
derivatives, amides/alkaloids, lignans/neoligans, flavonoids and miscellaneous compounds, while 
bioactivity studies revealed that the extracts and compounds displayed a broad spectrum of biological 
activities. Only 24 species of the genus Beilschmiedia have been studied phytochemically thus far. 
Therefore, there is a need to ascertain the pharmacological properties of the plant extracts and new 
compounds from this genus. More studies on the standardization and pharmacology of Beilschmiedia 
extracts need to be conducted to ascertain new pharmacological properties and their biochemical and 
physiological mechanisms. Furthermore, detailed preclinical toxicity, bioavailability, pharmacokinetics 
and pharmacodynamics of extracts of the species and their isolated compounds require additional 
investigation in order to verify their safety and determine their suitability as sources of some current 
medicines.  
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The genus Beilschmiedia is a pantropical genus 
of about 287 species mainly in Southeast Asia 
and Africa. About 81 Beilschmiedia species have 
been identified in inter-tropical Africa with 41 
species in Cameroon alone [1,2]. Plants of the 
genus Beilschmiedia have been listed in the 
plant list (2013). 287 of the genus names are 
accepted and the remaining names are either 
synonym or unresolved names. Revisional 
studies of the genus have been made in several 
regions, such as China, Madagascar, Australia 
and the Neotropics. In recent years, Kostermans 
described many new taxa of Beilschmiedia from 
Malay Peninsular and Southern Thailand [3-9]. 
Kochummen also revised Lauraceae and 
published in Tree Flora of Malaya [10]. Van der 
Werff studied the genera of Lauraceae in the 
Flora Malesiana Region and two reports on the 
synopsis of genus Beilschmiedia in Madagascar 
have been published [11,12]. 
 
The ethnopharmacological history of 
Beilschmiedia indicates that some species have 
been used in local medicine to treat various 
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conditions, including uterine tumors, rheumatism, 
pulmonary disorders, bacterial infections, malaria 
and tuberculosis [13-17]. Because of their 
versatile therapeutic traditional uses, extensive 
phytochemical investigations have been carried 
out on Beilschmiedia plants which led to isolation 
of numerous classes of secondary metabolites 
such as terpenoids, endiandric acid derivatives, 
essential oils, fatty acids, lignans/neolignans, 
flavonoids, amide/alkaloids and other 
components. Endiandric acid derivatives are 
considered to be the main constituents in 
Beilschmiedia species and are responsible for 
many of their biological and pharmacological 
activities [18-22].  
 
Both in vivo and in vitro experiments have 
indicated that the Beilschmiedia plant extracts 
possess a variety of pharmacological aspects 
with antioxidant, anti-inflammatory, cytotoxicity, 
antibacterial and antifungal activities [23-26]. 
With consideration of the importance of the 
therapeutic property of this genus to heal various 
ailments. Therefore a broader range of studies 
on the bioactivities need to be performed to 
ascertain the pharmacological properties. These 
gaps lead to systematic research activities on 
phytochemicals and pharmacology of genus 
Beilschmiedia. As extensive studies on 
Beilschmiedia species have not been conducted, 
there are thus significant opportunities to 
discover novel bioactive compounds and 
beneficial medicinal and pharmacological 
properties from various extracts of the species 
are warranted. The available information on 
various species belonging to the genus 
Beilschmiedia were collected via electronic 
search (using Pubmed, SciFinder, Scopus, 
Google Scholar, JCCC@INSTIRC and Web of 
Science) and a library search for articles 
published in peer-reviewed journals.  
 
DISTRIBUTION, BOTANICAL DESCRIPTION 
AND ETHNOBOTANY 
 
The genus Beilschmiedia comprises more of 
trees and rarely shrubs, and is usually 
distinguished from other genera of the Lauraceae 
by the following characteristics: paniculate or 
racemose inflorescences that are not strictly 
cymose at the terminal division, bisexual and 
trimerous flowers with six equal to subequal 
tepals, six to nine fertile stamens representing 
the outer two or three whorls, two-celled anthers, 
and fruits lacking cupules. This family is also 
recognized by the simple, alternate, stiff and 
aromatic elliptic to obovate leaves, and by the 
fruits often borne in a cup [27]. It is placed in the 
tribe Cryptocaryeae Nees together with other 
core genera such as Cryptocarya, Endiandra and 
Potameia based on the wood and bark anatomy 
and inflorescence structure [27]. Most of the 
species grow in tropical climates but few of them 
are native to the temperate regions. They are 
widespread in tropical Asia, Africa, Australia, 
New Zealand, Central America, Caribbean and 
South America [28]. In the Southeast Asia, the 
genus can be found in Myanmar, Vietnam, 
Cambodia, Thailand, Malaysia, Philippines, 
Indonesia and various islands, such as Sumatra 
and Java [29]. Beilschmiedia is categorized as a 
genus of forest trees, predominantly from low to 
high elevation. B. glauca is found in the upper 
evergreen forest and rarely found in the lowland 
evergreen forest, B. maingayi is found in the 
upper evergreen forest, over 1,200 m altitude, B. 
membranacea is found in the montane evergreen 
forest and B. palembanica is found in the lower 
evergreen forest to the upper evergreen forest. 
Many species of Beilschmiedia were reported in 
Bhutan and Sikkim, such as B. gammieana in 
montane forest with oaks, and broad leaves 
forest at 1,750 - 2,050 m altitude, B. assamica in 
subtropical forest and broad leaves forest and in 
temperate zone at 300-1,800 m altitude and B. 
roxburghiana in subtropical forest at 200 - 400 m 
altitude [30,31].  
 
Available literature and information show that 
several Beilschmiedia species have been applied 
as traditional medicines in various parts of the 
world. This genus has an economic importance 
in forest products for use as timber and herbal 
medicine. The most prevalent usages are for 
treating bone related problems which include 
arthritis, rheumatism and renal ailments. The 
important ethnomedicinal properties possessed 
by this genus can be the basis for further 
research to determine the phytochemical and 
pharmacological aspects of the above mentioned 
genus. The lists of the various medicinal uses of 
Beilschmiedia species in different parts of the 




Systematic phytochemical investigation is 
important to understand the pharmacology of the 
species as well as the mechanisms of action and 
for quality control purposes. The phytochemical 
studies of various species of the genus have 
successfully afforded numerous chemical 
components. They were essential oils, endiandric 
acid derivatives, amides and alkaloids, lignans 
and neolignans, flavonoids and also 
miscellaneous compounds (cyanogenic 
glycosides, benzopyran, benzenoid, terpenes, 
benzaldehyde, and fatty acid). The major 
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components of the essential oil compositions 
from several species of Beilschmiedia species 
are tabulated in Table 2. The phytochemical 




Table 1: Medicinal uses of several Beilschmiedia species 
 
Species  Local name Locality Plant parts and medicinal uses Ref 
B. gaboonensis  Kanda Cameroon Fruits: as appetite stimulants and spices 
Bark: analgesic and healing ointments 
[13] 
B. manii  Bubueh sapo Cameroon Fruits: as appetite stimulants, spices and 
treatment of dysentery and headache 
 
B. zenkeri  Not reported Cameroon Fruits: as appetite stimulants and spices  
B. cryptocaryoides  Not reported Madagascar Fruits/bark: to treat infectious diseases 
and malaria 
[21] 
B. acuta  Ndareh Cameroon Leaf: cancer and gastrointestinal 
infections 
[24] 
B. obscura  Not reported Cameroon Bark: gastrointestinal infection [25] 
B. sphaerocarpa  Not reported Indochina Bark :herbs to cure skin related disease 
such as scabies, acne and pustule 
[32] 
B. pahangensis  Not reported Malaysia Bark: as a drink after childbirth and also 
to assuage stomach ache, diarrhea and 
dysentery 
[33] 
B. tonkinensis  Perapoh Malaysia Leaf: to make medicine for easing pain, 
inflammation and broken bone 
 
B. madang  Medang merah Indonesia Wood: the decoction as an antimalarial 
preparation 
[34] 
B. anacardioides Ntseum Cameroon Stem bark: to cure uterine tumors, 
rubella, female genital infections, and 
rheumatisms 
[56] 
B. lancilimba  Not reported Cameroon Bark: to cure skin bacterial infections [57] 
B. podagrica  Kunana New Guinea Leaf/bark: treatment of stomach ailments [58] 
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cadinol (10.6%) 
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Sesquiterpene hydrocarbons (85.1%) 
















*All essential oils were extracted by hydrodistillation method and characterized by gas chromatography (GC) and 
gas chromatography-mass spectrometry (GC-MS) 
 
Table 3: Chemical constituents isolated from Beilschmiedia species 
 
Compound Species Plant part Ref 
Endiandric acid derivatives    
Beilcyclone A B. erythrophloia  Roots [18] 
Beilschmiedic acid A  B. anacardioides  Stem bark [44,46] 
Beilschmiedia sp.  Leaves [20] 
Beilschmiedic acid B  B. anacardioides  Stem bark [44] 
Beilschmiedic acid C  B. anacardioides  Stem bark [44,46] 
Beilschmiedia sp.  Leaves [20] 
Beilschmiedic acid D B. anacardioides  Stem bark [17] 
Beilschmiedic acid E  B. anacardioides  Stem bark  
Beilschmiedic acid F B. anacardioides  Stem bark [46] 
Beilschmiedic acid G B. anacardioides  Stem bark [46] 
Beilschmiedic acid H  Beilschmiedia sp.  Leaves [20] 
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Table 3: Chemical constituents isolated from Beilschmiedia species (continued) 
 
Compound Species Plant part Ref 
Beilschmiedic acid I  Beilschmiedia sp.  Leaves  
Beilschmiedic acid J  Beilschmiedia sp.  Leaves  
Beilschmiedic acid K  Beilschmiedia sp.  Leaves  
Beilschmiedic acid L  Beilschmiedia sp.  Leaves  
Beilschmiedic acid M  Beilschmiedia sp.  Leaves  
Beilschmiedic acid N  Beilschmiedia sp.  Leaves  
Beilschmiedic acid O  Beilschmiedia sp.  Leaves  
Beilschmiedin  B. anacardioides  Stem bark [17] 
Cryptobeilic acid A  B. cryptocaryoides  Bark [21] 
Cryptobeilic acid B  B. cryptocaryoides  Bark  
Cryptobeilic acid C  B. cryptocaryoides  Bark  
Cryptobeilic acid D  B. cryptocaryoides  Bark  
Endiandric acid A  B. obtusifolia  Leaves  [14] 
Endiandric acid B  B. tooram  Leaves  
Endiandric acid C  B. tooram  Leaves   
Endiandric acid H  B. fulva  Stem [42] 
Endiandric acid I  B. erythrophloia  Roots [43] 
Endiandric acid J  B. erythrophloia  Roots  
Endiandric acid K  B. tsangii  Roots [19] 
Endiandric acid L  B. tsangii  Roots  
Endiandric acid M  B. tsangii  Roots [45] 
Endiandramide A B. tsangii  Roots [19] 
Endiandramide B  B. tsangii  Roots  
Erythrophloin A  B. erythrophloia  Roots [18] 
Erythrophloin B  B. erythrophloia  Roots  
Erythrophloin C  B. erythrophloia  Roots  
Erythrophloin D  B. erythrophloia  Roots  
Erythrophloin E  B. erythrophloia  Roots  
Erythrophloin F  B. erythrophloia  Roots  
Ferrugineic acid A  B. ferruginea  Leaves/flower [22] 
Ferrugineic acid B  B. ferruginea  Leaves/flower  
Ferrugineic acid C  B. ferruginea  Leaves/flower  
Ferrugineic acid D  B. ferruginea  Leaves/flower  
Ferrugineic acid E  B. ferruginea  Leaves/flower  
Ferrugineic acid F  B. ferruginea  Leaves/flower  
Ferrugineic acid G  B. ferruginea  Leaves/flower  
Ferrugineic acid H  B. ferruginea  Leaves/flower  
Ferrugineic acid I  B. ferruginea  Leaves/flower  
Ferrugineic acid J  B. ferruginea  Leaves/flower  
Ferrugineic acid K  B. ferruginea  Leaves/flower  
Tsangibeilin A  B. tsangii  Roots [19] 
Tsangibeilin B  B. tsangii  Roots  
B. cryptocaryoides  Bark [21] 
Tsangibeilin C  B. tsangii  Roots [45] 
Tsangibeilin D  B. tsangii  Roots  
Tricyclotsangibeilin  B. tsangii  Roots  
Armepavine  B. brevipes  Leaves [48] 
Asimilobine  B. alloiophylla  Bark [49] 
(+)-Boldine  B. kunstleri  Bark  [47]  
B. alloiophylla  Bark [49] 
(+)-Cassythicine  B. kunstleri  Leaves/bark [47, 51] 
(+)-Dehatrine  B. madang  Wood [34] 
O,O-Dimethylannocherin A  B. brevipes  Leaves [48] 
O,O-Dimethylcoclaurine  B. brevipes  Leaves  
(+)-N-Dimethylphyllocaryptine  B. kunstleri  Bark [47, 49] 
(6,7-Dimethoxyisoquinolinyl)-(4′-methoxyphenyl)-
methanone  
B. brevipes  Leaves [48] 
(6,7-Dimethoxy-4-methylisoquinolinyl)-(4′-
methoxyphenyl)-methanone  
B. brevipes  Leaves  
Dioxamine  B. erythrophloia  Roots [18] 
Glaucine  B. podagrica  Leaves [60] 
2-Hydroxy-9-methoxyaporphine  B. alloiophylla  Bark [49] 
(+)-2-Hydroxy-1,9,10-trimethoxyaporphine  B. podagrica  Leaves [58] 
(+)-2-Hydroxy-l,9,10-trimethoxynoraporphine  B. podagrica  Leaves  
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Table 3: Chemical constituents isolated from Beilschmiedia species (continued) 
 
Compound Species Plant part Ref 
(+)-2,11-Dihydroxy-1,10-dimethoxyaporphine  B. podagrica  Leaves  
Isoboldine  B. alloiophylla  Bark [49] 
B. elliptica  Bark [62] 
B. podagrica Bark [58] 
B. tawa  Berries  [61] 
(-)-Isocaryachine  B. kunstleri  Bark [47] 
Isocorydine  B. podagrica  Leaves [58] 
(-)-Kunstleramide  B. kunstleri  Bark [47] 
Laurelliptine B. elliptica  Bark [60] 
B. podagrica  Bark [58] 
(+)-Laurotetanine  B. kunstleri  Bark [47] 
B. alloiophylla  Bark  [49] 
Liriodenine  B. alloiophylla  Bark  
(S)-3-Methoxynordomesticine B. alloiophylla  Bark  
(+)-N-Methylisococlaurine  B. kunstleri  Leaves [51] 
O-Methylvelucryptine  B. brevipes  Leaves [48] 
(+)-Nornuciferine  B. kunstleri  Bark [47] 
Noratherosperminine B. kunstleri  Bark  
Norarmepavine  B. brevipes  Leaves [48] 
(+)-Norboldine  B. kunstleri  Leaves [51] 
Obscurine  B. obscura  Stem bark [62] 
Oreobeiline B. alloiophylla  Bark [49] 
B. oreophila  Bark/wood [63] 
(-)-Pallidine  B. kunstleri  Leaves [51] 
Pipyahyine  B. zenkeri  Stem bark [16] 
Secoboldine  B. alloiophylla  Bark [49] 
6-Epioreobeiline  B. alloiophylla  Bark  
B. oreophila  Bark/wood [63] 
Zanthomamide  B. zenkeri  Stem bark [16] 
Beilschmin A  B. tsangii  Stem [50] 
Beilschmin B B. tsangii  Stem  
Beilschmin C  B. tsangii  Stem  
Beilschmin D  B. tsangii  Leaves [15] 
Beilschminol A  B. tsangii  Roots [19] 
Beilschminol B  B. tsangii  Roots [45] 
4α,5α-Epoxybeilschmin A  B. tsangii  Leaves [15] 
4α,5α-Epoxybeilschmin B  B. tsangii  Leaves  
Tsangin A  B. tsangii  Stem [50] 
Tsangin B  B. tsangii  Stem  
Tsangin C  B. tsangii  Roots [19] 
(+)-Kunstlerone  B. kunstleri  Leaves  [47, 51] 
Magnolol  B. volckii  Leaves [14] 
rel-(7R,8R,7′R,8′R)-3′,4′-methylenedioxy-3,4,5,5′-
tetramethoxy-7,7′-epoxylignan  
B. tsangii  Roots [19] 
rel-(7R,8R,7′R,8′R)-3,4,3′,4′-dimethylenedioxy-
5,5′-dimethoxy-7,7′-epoxylignan  
B. tsangii  Roots  
rel-(7S,8S,7′R,8′R)-3,3′,4,4′,5,5′-
hexamethoxylignan  
B. tsangii  Roots  
B. tsangii  Stem [50] 
Beilschmieflavonoid A  B. zenkeri  Stem bark [16] 
Beilschmieflavonoid B  B. zenkeri  Stem bark  
2′,6′-Dihydroxy-4′-isopentenyloxy-3,4(3′′,3′′-
dimethylpyrano)chalcone  
B. tovarensis  Wood  [52] 
5-Hydroxy-7,8-dimethoxyflavanone  B. zenkeri  Stem bark [16] 
Kaempferol 3-rhamnoside  B. miersii  Leaves  [53] 
Luteolin O-glucoside  B. miersii  Leaves   
Quercetin 5-methyl ether B. miersii  Leaves   
Quercetin 3-rhamnoside  B. miersii  Leaves   
Quercetin 3-glucuronide  B. miersii  Leaves   
4, 2′, 6′-Trihydroxy-3′,4′-methylenedioxo-3-
isopentenylchalcone  
B. tovarensis  Wood  [52] 
(2S,4R)-5,6,7-Trimethoxyflavan-4-ol  B. zenkeri  Stem bark [16] 
(2S,4R)-4,5,6,7-Tetramethoxyflavan  B. zenkeri  Stem bark  
Oligandrol B. oligandra  Bark  [14] 
B. erythrophloia Roots [43] 
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Table 3: Chemical constituents isolated from Beilschmiedia species (continued) 
 
Compound Species Plant part Ref 
Betulinic acid  B. zenkeri  Stem bark [16] 
Sitosterol 3-O-β-D-glucopyranoside  B. zenkeri  Stem bark  
Bisabolene  B. anacardioides Stem bark [17] 
Tricosanoic acid  B. anacardioides  Stem bark  
Suberosol B  B. erythrophloia  Roots [18] 
24(S)-3β-Hydroxystigmast-5-en-7-one  B. erythrophloia  Roots  
Lupeol  B. erythrophloia  Roots  
3-O-Acetyl-epi-betulinic acid  B. erythrophloia  Roots  
Methyl oleate  B. erythrophloia  Roots  
Methyl palmitate  B. erythrophloia  Roots  
Methyl linoleate  B. erythrophloia  Roots  
4-Hydroxy-3-methoxybenzaldehyde  B. erythrophloia  Roots  
B. tsangii  Roots [19] 
B. tsangii  Stem [50] 
α-Tocopheryl quinone  B. erythrophloia Roots  
B. tsangii  Stem [50] 
6β-Hydroxystigmast-4-en-3-one  B. erythrophloia  Roots [18] 
B. tsangii  Roots [19] 
B. tsangii  Stem [50] 
3β-Hydroxystigmast-5-en-7-one  B. tsangii  Stem [50] 
Caryophyllene oxide  B. erythrophloia Roots [43] 
Dehydrooligandrol methyl ether    B. erythrophloia  Roots  
Farnesylol  B. erythrophloia  Roots  
Oligandrol methyl ether  B. erythrophloia  Roots  
β-Sitostenone  B. erythrophloia  Roots  
B. tsangii  Stem [50] 
3,4,5-Trimethoxybenzaldehyde  B. tsangii  Roots [45] 
Eudesm-4(15)-ene-1β,6α-diol  B. tsangii  Roots  
(4R,5R)-4,5-Dihydroxycaryophyll-8(13)-ene  B. tsangii  Roots  
Octahydro-4-hydroxy-3α-methyl-7-methylene-α-(1-
methylethyl)-1H-indene-1-methanol  
B. tsangii  Roots  
Ursolic acid  B. tsangii  Roots  
(+)-5-Hydroxybarbatenal                                      B. tsangii  Roots  
Sitosterol 3-β-D-glucopyranoside  B. anacardioides  Stem bark [46] 
β-Amyrone  B. alloiophylla  Bark [49] 
4-Hydroxybenzaldehyde   B. tsangii  Stem [50] 
α-Tocospiro B  B. tsangii Stem  
Ergosta-4,6,8(14),22-tetraen-3-one  B. tsangii  Stem  
6α-Hydroxystigmast-4-en-3-one  B. tsangii  Stem  
Stigmast-4-en-3,6-dione  B. tsangii  Stem  
β-Sitosterol  B. zenkeri  Stem bark [16] 
B. tsangii  Roots [19] 
B. anacardioides  Stem bark [44] 
B. tsangii  Stem [50] 
Taxiphyllin B. collina  Leaves [54] 
 
BIOLOGICAL ACTIVITIES  
 
The literature study reveals the need for a 
thorough investigation of the pharmacological 
characteristics of the extracts and isolated 
compounds from Beilschmiedia genus. The 
biological activities including anti-inflammatory, 
antioxidant, acetylcholinesterase, anti-α-
glucosidase, anti-leishmanial, antifungal, 
antimalarial, anticancer, antitubercular, 
antiplasmodial, antibacterial and cytotoxicity 
have been reported in some works. Indeed, the 
genus Beilschmiedia has been exploited 
traditionally thus revealed the medicinal variation 
if possesses. In addition, several species that 
have been used traditionally to treat some types 
of ailments have not been investigated for their 
biological activities at all. Thus, this is an 
opportunity to find new pharmacological 
properties from this genus, not to mention 
promising sources for drugs, such as for cancer, 
hernia, skin and digestive diseases. Furthermore, 
the toxicity of the genus members has not been 
studied from this genus. The information of the 
qualification of the extracts are very important to 
be applied as drugs. 
 
Anti-inflammatory activity  
 
A methanol extract of the roots of B. tsangii has 
shown potent inhibition of NO production, and 
negative cytotoxicity against RAW 264.7 cells 
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[19]. Huang et al [19] also studied the anti-
inflammatory activity of several compounds 
isolated from B. tsangii. They found that 
endiandramide A-B exhibited significant iNOS 
inhibitory activity against RAW 264.7 cells at the 
concentration range of 0.1 - 100 μM. A year later, 
they reported moderate iNOS inhibitory activity 
for endiandric acid M. They also suggested that 
endiandramide B and endiandric acids K-M 
having the same skeleton but with different 
substituents at C-8, exhibited ascending degrees 
of iNOS inhibitory activity in the order: 
endiandramide B (16.40 μM) > endiandric acid M 
(31.70 μM) > endiandric acid L (39.56 μM) > 
endiandric acid K (58.21 μM). This suggests that 
the iNOS potency of the substituent at C-8 could 
be arranged as N-isobutylamido group > an α,β-
unsaturated carboxylic acid group > a carboxylic 
acid group. Endiandric acid M, having four fewer 
methylenes than endiandric acid L, showed 
stronger potency than endiandric acid L. This 
also suggests that fewer methylenes in the alkyl 
side of endiandric acid analogues result in 
greater potency of iNOS inhibitory activity [45]. In 
addition, the mixture extracts of the leaves and of 
B. erythrophloia showed weak inhibitory activity 
of NO production at dose of 25 µg/mL [23]. 
 
Antibacterial activity  
 
B. cinnamomea root extract demonstrated 
moderate activity against Enterobacter 
aerogenes EA294 with minimum inhibitory 
concentration (MIC) value of 64 µg/mL [55]. 
Three years later, Fankam et al [25] reported on 
methanol fruits extract of B. obscura which 
showed strong activity against Escherichia coli 
ATCC8739 with MIC value of 16 μg/mL. Besides, 
another study reported on B. tovarensis wood 
extract displayed significant results against 
Staphylococcus aureus and Enterococcus 
faecalis [52]. Anti-bacterial activity on 
methoxylated flavonoid derivatives from B. 
zenkeri, showed that beilschmieflavonoid B 
displayed the activity against Streptococcus 
minor with MIC value of 197.5 µM. Pipyahyine 
that was also isolated from this species, showed 
moderate activity against Bacillus subtilis and 
Pseudomonas agarici with MIC of 163 and 81.5 
µM, respectively [16].  
 
Talontsi et al [21] and a co-worker identified 
cryptobeilic acids A-D, tested for anti-bacterial 
activity and showed that cryptobeilic acid A gave 
moderate activity against Escherichia coli (MIC 
value of 10 μM), while cryptobeilic acid B was 
active against Pseudonamas stutzeri with a MIC 
value of 10 μM. In another study, Chouna et al 
[44] reported that beilschmiedic acid C 
demonstrated the best activity against Bacillus 
subtilis and Micrococcus luteus with MIC of 89.5, 
5.58 and 11.1 µM, respectively. Antibacterial 
activity on endiandric acid derivatives was further 
studied by Williams et al [20]. It was observed 
that beilschmiedic acid A, K and L gave 
moderate activity against clinical isolate of 
methicillin-resistant Staphylococcus aureus with 




The in vitro cytotoxicity of the methanol extracts 
of B. erythrophloia showed weak activity against 
HUVEC (human umbilical vein endothelial cells), 
MCF-7 (breast cancer cell) line and HL-60 
(human promyelocytic leukemia cell) cell lines, 
showed weak activity with MIC values reaching 
more than 100 μg/mL at the range of 
concentration 25 - 500 µg/mL [23]. In another 
study, the B. acuta fruits, leaves and bark 
extracts showed the inhibition of CCRF-CEM 
leukemia cell growth of 65.17, 26.35 and 21.33 
%, respectively, as measured by the resazurin 
reduction assay. In addition, the leaves extract 
also displayed significant activity towards cell 
lines HCT116p53 (colon cancer cell), MDA-MB-
231 (human breast carcinoma cell) and U87MG 
(human glioblastoma cell) with IC50 of 4.79, 6.45, 
and 7.46 µg/mL, respectively. The bark extract 
also showed activity against the cell line MDA-
MB-231 with an IC50 value of 6.66 µg/mL [24].  
 
The in vitro cytotoxicity properties of the leaf oil 
of B. erythrophloia were evaluated against OEC-
M1 (human oral squamous cancer cell), J5 
(human hepatocellular carcinoma cell), A549 
(human lung adenocarcinoma cell), HT-29 
(human colon cancer cell), UACC-62 (human 
melanoma cell) and K562 (human leukemic cell) 
and shows IC50 values of 32.6, 48.6, 38.7, 18.9, 
5.8, and 6.8 μg/mL, respectively [39]. Williams et 
al [20] screened the isolated endiandric acids for 
their in vitro cytotoxicity activity against NCI-
H460 (large cell lung carcinoma), PC-3 (prostate 
adenocarcinoma) and M14 (amelanotic 
melanoma cell) lines using a MTT-based assay. 
They managed to find moderate activity of 
beilschmiedic acid L, I and K against the NCI-
H460 cell lines with IC50 values of 4.4, 5.5 and 
5.9 µM, respectively. (-)-Kunstleramide was 
investigated on MTT assays against A375 
(human melanoma cell), HT-29 (human colon 
adenocarcinoma cell), WRL-68 (normal hepatic 
cell), A549 and PC-3 cells. The results showed 
moderate activity among all the tested cell lines 
with EC50 values in the range of 44.74 - 73.87 
μg/mL [47]. Chen et al [50] studied the in vitro 
cytotoxicity of several compounds isolated from 
B. tsangii. They found that tsangin A-B, α-
tocospiro B and beilschmin A displayed from 
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medium to strong activity against the P-388 
(murine leukemia cell) line. In addition, α-
tocospiro B, exhibited the most cytotoxic against 
the HT-29 cell line. In addition, six alkaloids 
isolated from B. brevipes were tested for in vitro 
cytotoxic activity against P-388 cell lines, O, O-
dimethylcoclaurine exhibited significant 
cytotoxicity with an IC50 of 6.5 μg/mL [48]. 
 
Anti-plasmodial activity  
 
According to Lenta et al [16] among the 
methoxylated flavonoid tested for in vitro anti-
plasmodial activity, 5-hydroxy-7,8-
dimethoxyflavanone exhibited the most 
significant activity against Plasmodium 
falciparum chloroquine-resistant strain W2 giving 
an IC50 value of 9.3 µM. The other compounds 
which showed remarkable activity were 
pipyahyine and betulinic acid which gave IC50 
values of 3.7 and 5.2 µM, respectively. Talontsi 
et al [21] studied the anti-plasmodial activity of 
the isolated endiandric acid derivatives from B. 
cryptocaryoides. Cryptobeilic acid B exhibited 
anti-plasmodial activity against the erythrocytic 
stages of chloroquine-resistant Plasmodium 
falciparum strain NF54, followed by tsangibeilin B 
and cryptobeilic acid D at a concentration of 10 
μg/mL.  
 
Anti-tubercular activity  
 
Chen et al [15] investigated the in vitro anti-
tubercular effects of the isolates from the leaves 
of B. tsangii against Mycobacterium tuberculosis 
90 - 221387. They reported that among the 
furanoid lignans, beilschmin A-B exhibited potent 
activity with IC50 values of 2.5 and 7.5 µM, 
respectively. Both compounds also exhibited 
corresponding epoxy-analogues, 4α,5α-
epoxybeilschmin A-B and this revealed that 
epoxidation of the C-4,5 bond would result in 
reduced anti-tubercular activity. In another study 
of anti-tubercular activity, Yang et al [18] verified 
that erythrophloin C showed significant activity 
against Mycobacterium tuberculosis H37Rv (MIC 
of 50 µg/mL), comparable to ethambutol (MIC of 
6.25 μg/mL).  
 
Anti-cancer activity  
 
The anti-apoptotic proteins Bcl-2, Bcl-xL, Bcl-w, 
Mcl-1, and A1, members of the Bcl-2 family, have 
become attractive molecular targets for cancer 
treatment. The discovery of dual inhibitors acting 
on Bcl-xL and Mcl-1 could play a significant role 
in cancer treatment. Apart from that, Apel et al 
[22] had investigated the anti-cancer activity of 
isolated endiandric acid from B. ferruginea, 
ferrugineic acid A-K against anti-apoptotic 
proteins Bcl-xL and Mcl-1 by using a 
fluorescence polarization assay. Ferrugineic acid 
B-C and ferrugineic acid J were proved to have 
significantly exhibited binding affinity for both 
anti-apoptotic proteins, Bcl-xL.  
 
Meanwhile, ferrugineic acid D showed only a 
strong inhibiting activity for anti-apoptotic protein, 
Mcl-1. Considering the weak binding affinity for 
Mcl-1 of other tested compounds, it could be 
postulated that the length of the saturated carbon 
side chain (preferentially five or seven CH2 
groups) associated with a terminal 4-
hydroxyphenyl ring, play a crucial role for Bcl-xL 
and Mcl-1 binding affinities. 
 
Antioxidant, antifungal, antimalarial, anti-α-
glucosidase, acetyl-cholinesterase, and anti-
leishmanial activities  
 
B. erythrophloia extracts showed moderate 
DPPH radical scavenging assay with an EC50 
value of 13.51 µg/mL, comparable to ascorbic 
acid and quercetin that had EC50 values of 1.5 
and 2.3 µg/mL, respectively [23]. Mollataghi et al 
[47,49] have investigated the antioxidant activity 
by DPPH assay on a new neolignan, (+)-
kunstlerone and a new dienamide, (-) 
kunstleramide. They found that (+)-kunstlerone 
showed strong antioxidant activity with SC50 of 
20.0 µg/mL, while (-)-kunstleramide exhibited 
very poor dose-dependent inhibition with SC50 of 
179.5 ± 4.4 µg/mL, at the concentration of 200 - 
25 µg/mL. The bark extract of B. cinnamomea 
exhibited moderate in vivo anti-fungal activity 
with MIC and MFC values in the range of 3.12-
6.25 mg/mL, towards six fungal; Candida 
albicans, Cryptococcus neoformans, Candida 
tropicali, Candida lusitaniae, Candida 
guilliermondii and Candida glabrata [26].  
 
Mollataghi et al [49] have reported the anti-fungal 
activity of the new alkaloid, 2-hydroxy-9-
methoxyaporphine isolated from B. alloiophylla. 
This compound demonstrated good activity 
against Candida albicans with MIC value of 8.0 
µg/mL.  More than a decade ago, Kitagawa et al 
[34] successfully isolated a bisbenzylisoquinoline 
alkaloid, (+)-dehatrine from the Indonesian 
medicinal plant, B. madang. The compound was 
found to exhibit a potent inhibitory activity against 
the proliferation of the malarial pathogen, 
Plasmodium falciparum K1 strain (IC50 of 0.17 
µM), with almost the same activity as quinine 
(IC50 of 0.27 µM). Mollataghi et al [49] studied the 
in vitro α-glucosidase activity of the isolated 
compounds from B. alloiophylla. Three 
compounds that were found to have moderate 
activity, were characterized as oreobeiline, 6-
epioreobeiline and (S)-3-methoxynordomesticine. 
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In addition, for cholinesterase and leishmanial 
activities, the results suggested that 2-hydroxy-9-
methoxyaporphine, laurotetanine and liriodenine 
displayed significant acetylcholinesterase (AChE) 
activity. Meanwhile, the authors deemed that 





This compilation includes the traditional uses, 
phytochemical and pharmacological aspects of 
the genus Beilschmiedia, and especially provides 
some analysis of the literature published. Some 
members of the genus are reported to possess 
medicinal properties and are used to treat 
various ailments. Endiandric acid derivatives are 
major constituents of this genus, and are 
important chemotaxonomic markers used to 
identify Beilschmiedia plant species from a 
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